American Portfolios Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
American Portfolios Advisors's PFE Position: Q3 2022 in Review
American Portfolios Advisors reduced its Pfizer (PFE) stake by 5.6% in Q3 2022, selling an estimated $302K and leaving 103,798 shares worth $4.54M. The position accounts for 0.19% of the portfolio, ranked #105.
American Portfolios Advisors first reported a position in PFE in Q4 2017 and has held it in 20 quarters since. The position peaked at $6.43M in Q4 2021. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- American Portfolios Advisors held 103,798 shares of Pfizer worth $4.54M as of Q3 2022.
- American Portfolios Advisors sold 6,214 Pfizer shares in Q3 2022, an estimated $302K.
- Pfizer made up 0.19% of American Portfolios Advisors's portfolio in Q3 2022, its #105 holding.
- American Portfolios Advisors first reported a position in Pfizer in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Pfizer position peaked at $6.43M in Q4 2021.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.